Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Cabazitaxel

A semi-synthetic taxane that stops cell division by stabilising microtubules; approved in the United States in 2010 for metastatic castration-resistant prostate cancer previously treated with docetaxel. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?It is made by semi-synthesis from 10-deacetylbaccatin III, extracted from yew needles: the same genus of trees (Taxus) from which paclitaxel was isolated.

CabazitaxelGo to the active ingredient →
CabazitaxelActive ingredientCabazitaxelCat. No. P-C001-001CAS 183133-96-2
Cabazitaxel-d9Isotopically labelledCabazitaxel-d9Cat. No. P-C001-002CAS 1383572-19-7

EDQM standards 5

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.